Crude Carriers, a shipping company formed by Capital Maritime to acquire crude tankers, will see its quiet period end on Tuesday, April 20th. On March 11th, the company raised $257 million by offering 13.5 million shares at $19, at the low end of its $19-$21...read more
All four companies that were slated to go public this week successfully completed their deals, though three priced at the bottom of their proposed ranges and one was forced to cut its deal size by 18%. Two of the four IPOs, Baltic Trading Limited (BALT)...read more
Crude Carriers, a newly formed shipping business incorporated in the Marshall Islands to focus on the crude tanker industry, raised $257 million by offering 13.5 million shares at $19, at the low end of the original range of $19-$21. Crude Carriers will list on...read more
The following IPOs are expected to price this week:
AVEO Pharmaceuticals, which is developing a renal cell carcinoma drug similar to blockbuster Avastin, plans to raise $98 million by offering 7 million shares at a price range of $13-$15. At the...read more
Crude Carriers quiet period ends April 20
Crude Carriers, a shipping company formed by Capital Maritime to acquire crude tankers, will see its quiet period end on Tuesday, April 20th. On March 11th, the company raised $257 million by offering 13.5 million shares at $19, at the low end of its $19-$21...read more
Four IPOs test investor appetite, post mixed performances this week
All four companies that were slated to go public this week successfully completed their deals, though three priced at the bottom of their proposed ranges and one was forced to cut its deal size by 18%. Two of the four IPOs, Baltic Trading Limited (BALT)...read more
Crude Carriers prices IPO at $19, at low end of the $19-$21 range
Crude Carriers, a newly formed shipping business incorporated in the Marshall Islands to focus on the crude tanker industry, raised $257 million by offering 13.5 million shares at $19, at the low end of the original range of $19-$21. Crude Carriers will list on...read more
4 IPOs planned for the week of Mar 8
The following IPOs are expected to price this week:
AVEO Pharmaceuticals, which is developing a renal cell carcinoma drug similar to blockbuster Avastin, plans to raise $98 million by offering 7 million shares at a price range of $13-$15. At the...read more